Solulin reduces infarct volume and regulates gene-expression in transient middle cerebral artery occlusion in rats

BMC Neuroscience

Volumn 12, Issue , 2011, Pages

  Ryang, Yu Mi ^a,b   Dang, Jon ^c   Kipp, Markus ^c   Petersen, Karl Uwe ^d   Fahlenkamp, Astrid V ^b,c   Gempt, Jens ^a   Wesp, Dominik ^e   Rossaint, Rolf ^b   Beyer, Cordian ^c   Coburn, Mark ^b  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^b UNIVERSITY HOSPITAL RWTH AACHEN   (Germany)

^c RWTH AACHEN UNIVERSITY   (Germany)

^d PAION Deutschland GmbH Aachen   (Germany)

^e UNIVERSITY MEDICAL CENTER GÖTTINGEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CD11B ANTIGEN; CYCLOPHILIN A; GELATINASE B; GLIAL FIBRILLARY ACIDIC PROTEIN; HYPOXANTHINE PHOSPHORIBOSYLTRANSFERASE; INTERLEUKIN 1BETA; INTERLEUKIN 6; RECOMBINANT THROMBOMODULIN; SOLULIN; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; NEUROPROTECTIVE AGENT; RECOMBINANT PROTEIN; SOLULIN PROTEIN; THROMBIN RECEPTOR;

ANIMAL EXPERIMENT; ARTICLE; BRAIN EDEMA; BRAIN REGION; COGNITIVE DEFECT; CONTROLLED STUDY; DOWN REGULATION; DRUG EFFECT; GENE EXPRESSION; MALE; MIDDLE CEREBRAL ARTERY OCCLUSION; MORTALITY; NEUROPROTECTION; NONHUMAN; RAT; ANIMAL; BRAIN INFARCTION; CEREBRAL ARTERY DISEASE; DISEASE MODEL; GENE EXPRESSION REGULATION; GENETICS; PATHOLOGY; PHYSIOLOGY; SPRAGUE DAWLEY RAT; TRANSIENT ISCHEMIC ATTACK;

ANIMALS; BRAIN INFARCTION; DISEASE MODELS, ANIMAL; GENE EXPRESSION REGULATION; INFARCTION, MIDDLE CEREBRAL ARTERY; ISCHEMIC ATTACK, TRANSIENT; MALE; NEUROPROTECTIVE AGENTS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, THROMBIN; RECOMBINANT PROTEINS;

RATTUS;

EID: 84855280562     PISSN: None     EISSN: 14712202     Source Type: Journal    
DOI: 10.1186/1471-2202-12-113     Document Type: Article

References (39)

1. Mosnier LO, Meijers JC, Bouma BN. Regulation of fibrinolysis in plasma by TAFI and protein C is dependent on the concentration of thrombomodulin. Thromb Haemost 2001, 85:5-11.
2. Abeyama K, Stern DM, Ito Y, Kawahara K, Yoshimoto Y, Tanaka M, Uchimura T, Ida N, Yamazaki Y, Yamada S, Yamamoto Y, Yamamoto H, Iino S, Taniguchi N, Maruyama I. The N-terminal domain of thrombomodulin sequesters high-mobility group-B1 protein, a novel anti-inflammatory mechanism. J Clin Invest 2005, 115:1267-74. 1077171, 15841214.
3. Light DR, Glaser CB, Betts M, Blasko E, Campbell E, Clarke JH, McCaman M, McLean K, Nagashima M, Parkinson JF, Rumennik G, Young T, Morser J. The interaction of thrombomodulin with Ca2+. Eur J Biochem 1999, 262:522-33. 10.1046/j.1432-1327.1999.00398.x, 10336638.
4. Wang W, Nagashima M, Schneider M, Morser J, Nesheim M. Elements of the primary structure of thrombomodulin required for efficient thrombin-activable fibrinolysis inhibitor activation. J Biol Chem 2000, 275:22942-7. 10.1074/jbc.M001760200, 10801821.
5. Esmon NL, Owen WG, Esmon CT. Isolation of a membrane-bound cofactor for thrombin-catalyzed activation of protein C. J Biol Chem 1982, 257:859-64.
6. Esmon CT, Esmon NL, Harris KW. Complex formation between thrombin and thrombomodulin inhibits both thrombin-catalyzed fibrin formation and factor V activation. J Biol Chem 1982, 257:7944-7.
7. Fulcher CA, Gardiner JE, Griffin JH, Zimmerman TS. Proteolytic inactivation of human factor VIII procoagulant protein by activated human protein C and its analogy with factor V. Blood 1984, 63:486-9.
8. Kalafatis M, Rand MD, Mann KG. The mechanism of inactivation of human factor V and human factor Va by activated protein C. J Biol Chem 1994, 269:31869-80.
9. Su EJ, Fredriksson L, Geyer M, Folestad E, Cale J, Andrae J, Gao Y, Pietras K, Mann K, Yepes M, Strickland DK, Betsholtz C, Eriksson U, Lawrence DA. Activation of PDGF-CC by tissue plasminogen activator impairs blood-brain barrier integrity during ischemic stroke. Nat Med 2008, 14:731-7. 10.1038/nm1787, 2811427, 18568034.
10. Esmon CT. Do-all receptor takes on coagulation, inflammation. Nat Med 2005, 11:475-7. 10.1038/nm0505-475, 15875050.
11. Conway EM, Van de Wouwer M, Pollefeyt S, Jurk K, Van Aken H, De Vriese A, Weitz JI, Weiler H, Hellings PW, Schaeffer P, Herbert JM, Collen D, Theilmeier G. The lectin-like domain of thrombomodulin confers protection from neutrophil-mediated tissue damage by suppressing adhesion molecule expression via nuclear factor kappaB and mitogen-activated protein kinase pathways. J Exp Med 2002, 196:565-77. 10.1084/jem.20020077, 2193995, 12208873.
12. Van de Wouwer M, Collen D, Conway EM. Thrombomodulin-protein C-EPCR system integrated to regulate coagulation and inflammation. Arterioscler Thromb Vasc Biol 2004, 24:1374-83. 10.1161/01.ATV.0000134298.25489.92, 15178554.
13. Zea Longa EL, Weinstein PR, Carlson S, Cummins R. Reversible middle cerebral artery occlusion without craniectomy in rats. Stroke 1989, 20:84-91. 10.1161/01.STR.20.1.84, 2643202.
14. Belayev L, Alonso OF, Busto R, Zhao W, Ginsberg MD. Middle cerebral artery occlusion in the rat by intraluminal suture. Neurological and pathological evaluation of an improved model. Stroke 1996, 27:1616-22. 10.1161/01.STR.27.9.1616, 8784138.
15. Ryang YM, Fahlenkamp AV, Rossaint R, Wesp D, Loetscher PD, Beyer C, Coburn M. Neuroprotective effects of argon in an in vivo model of transient middle cerebral artery occlusion in rats. Crit Care Med 2011, 39:1448-53. 10.1097/CCM.0b013e31821209be, 21336110.
16. Belayev L, Khoutorova L, Deisher TA, Belayev A, Busto R, Zhang Y, Zhao W, Ginsberg MD. Neuroprotective effect of SolCD39, a novel platelet aggregation inhibitor, on transient middle cerebral artery occlusion in rats. Stroke 2003, 3:758-63.
17. Zausinger S, Hungerhuber E, Baethmann A, Reulen H, Schmid-Elsaesser R. Neurological impairment in rats after transient middle cerebral artery occlusion: a comparative study under various treatment paradigms. Brain Res 2000, 863:94-105. 10.1016/S0006-8993(00)02100-4, 10773197.
18. De Kok JB, Roelofs RW, Giesendorf BA, Pennings JL, Waas ET, Feuth T, Swinkels DW, Span PN. Normalization of gene expression measurements in tumor tissues: comparison of 13 endogenous control genes. Lab Invest 2005, 85:154-9.
19. Nakajima K, Kohsaka S. Microglia: neuroprotective and neurotrophic cells in the central nervous system. Curr Drug Targets Cardiovasc Haematol Disord 2004, 4:65-84. 10.2174/1568006043481284, 15032653.
20. Liu T, Clark RK, McDonnell PC, Young PR, White RF, Barone FC, Feuerstein GZ. Tumor necrosis factor-expression in ischemic neurons. Stroke 1994, 25:1481-8. 10.1161/01.STR.25.7.1481, 8023366.
21. Wang X, Yue TL, Barone FC, White RF, Gagnon RC, Feuerstein GZ. Concomitant cortical expression of TNF- and IL-1 mRNAs follows early response gene expression in transient focal ischemia. Mol Chem Neuropathol 1994, 23:103-14. 10.1007/BF02815404, 7702701.
22. Buttini M, Appel K, Sauter A, Gebicke-Haerter PJ, Boddeke HW. Expression of tumor necrosis factor alpha after focal cerebral ischaemia in the rat. Neuroscience 1996, 1:1-16.
23. Yang GY, Gong C, Qin Z, Ye W, Mao Y, Bertz AL. Inhibition of TNFalpha attenuates infarct volume and ICAM-1 expression in ischemic mouse brain. Neuroreport 1998, 9:2131-4. 10.1097/00001756-199806220-00041, 9674607.
24. Nawashiro H, Martin D, Hallenbeck JM. Inhibition of tumor necrosis factor and amelioration of brain infarction in mice. J Cereb Blood Flow Metab 1997, 2:229-32.
25. Clausen BH, Lambertsen KL, Babcock AA, Holm TH, Dagnaes-Hansen F, Finsen B. Interleukin-1beta and tumor necrosis factor-alpha are expressed by different subsets of microglia and macrophages after ischemic stroke in mice. J Neuroinflammation 2008, 5:46. 10.1186/1742-2094-5-46, 2585073, 18947400.
26. Reichmann G, Schroeter M, Jander S, Fischer HG. Dendritic cells and dendritic-like microglia in focal cortical ischemia of the mouse brain. J Neuroimmunol 2002, 129:125-32. 10.1016/S0165-5728(02)00184-4, 12161028.
27. Benveniste EN. Cytokine actions in the central nervous system. Cytokine Growth Factor Rev 1998, 9:259-75. 10.1016/S1359-6101(98)00015-X, 9918124.
28. Wang X, Yue TL, Young PR, Barone FC, Feuerstein GZ. Expression of interleukin-6, c-fos, and zif268 mRNAs in rat ischemic cortex. J Cereb Blood Flow Metab 1995, 15:166-71. 10.1038/jcbfm.1995.18, 7798334.
29. Ali C, Nicole O, Docagne F, Lesne S, MacKenzie ET, Nouvelot A, Buisson A, Vivien D. Ischemia-induced interleukin-6 as a potential endogenous neuroprotective cytokine against NMDA receptor-mediated excitotoxicity in the brain. J Cereb Blood Flow Metab 2000, 20:956-66.
30. Wang X, Yue TL, Barone FC, Feuerstein GZ. Demonstration of increased endothelial-leukocyte adhesion molecule-1 mRNA expression in rat ischemic cortex. Stroke 1995, 26:1665-8. 10.1161/01.STR.26.9.1665, 7544926.
31. Sofroniew MV, Vinters HV. Astrocytes: biology and pathology. 2010, 119:7-35.
32. Lukes A, Mun-Bryce S, Lukes M, Rosenberg GA. Extracellular matrix degradation by metalloproteinases and central nervous system diseases. Mol Neurobiol 1999, 19:267-84. 1111, 10.1007/BF02821717, 10495107.
33. Rosenberg GA. Matrix metalloproteinases and their multiple roles in neurodegenerative diseases. Lancet Neurol 2009, 8:205-16. 10.1016/S1474-4422(09)70016-X, 19161911.
34. Mandler RN, Dencoff JD, Midani F, Ford CC, Ahmed W, Rosenberg GA. Matrix metalloproteinases and tissue inhibitors of metalloproteinases in cerebrospinal fluid differ in multiple sclerosis and Devic's neuromyelitis optica. Brain 2001, 124:493-8. 10.1093/brain/124.3.493, 11222449.
35. Asahi M, Wang X, Mori T, Sumii T, Jung JC, Moskowitz MA, Fini ME, Lo EH. Effects of matrix metalloproteinase-9 gene knock-out on the proteolysis of blood-brain barrier and white matter components after cerebral ischemia. J Neurosci 2001, 21:7724-32.
36. Copin JC, Merlani P, Sugawara T, Chan PH, Gasche Y. Delayed matrix metalloproteinase inhibition reduces intracerebral hemorrhage after embolic stroke in rats. Exp Neurol 2008, 213:196-201. 10.1016/j.expneurol.2008.05.022, 2557056, 18590727.
37. Wang X, Jung J, Asahi M, Chwang W, Russo L, Moskowitz MA, Dixon CE, Fini ME, Lo EH. Effects of matrix metalloproteinase-9 gene knock-out on morphological and motor outcomes after traumatic brain injury. J Neurosci 2000, 20:7037-42.
38. Griffin JH, Fernández JA, Gale AJ, Mosnier LO. Activated protein C. J Thromb Haemost 2007, 5(Suppl 1):73-80.
39. Esmon CT. The impact of the inflammatory response on coagulation. Thromb Res 2004, 114:321-7. 10.1016/j.thromres.2004.06.028, 15507261.